Ductal carcinoma in situ (DCIS) of the breast is characterised by abnormal cells in the milk ducts which have not spread into the breast tissue. An international study (BIG 3-07/TROG 07.01) shows that after breast conserving surgery, higher radiation doses to the part of the breast where the DCIS
With a pandemic sweeping the globe, it can be easy to forget about sun safety. But it’s a dangerous threat we face and being vigilant about skin cancer risk factors is important. It may seem easy to cover up in winter, since it’s so cold – but your face, head
Paving the way for success in prostate cancer treatment, TROG Cancer Research are helping to reduce common side effects and the length of treatment with the TROG 15.01 SPARK Trial. The clinical trial, led by Professor Paul Keall and Professor Jarad Martin, proposes the use of kilovoltage intrafraction monitoring (KIM) alongside stereotactic body radiotherapy (SBRT) to provide
The situation around the COVID-19 pandemic is rapidly changing. Like many other businesses, TROG Cancer Research is adapting to this situation to ensure the safety and welfare of staff, whilst aiming to limit interruptions to our business operations. Some of those measures include: All TROG Cancer Research Staff are
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Latest News
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292
